Protalix BioTherapeutics Inc (PLX)
1.395
-0.02
(-1.06%)
USD |
NYAM |
Nov 15, 14:39
Protalix BioTherapeutics Free Cash Flow (Quarterly): -3.782M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -3.782M |
| March 31, 2024 | 3.59M |
| December 31, 2023 | 3.345M |
| September 30, 2023 | -7.335M |
| June 30, 2023 | 4.769M |
| March 31, 2023 | -3.246M |
| December 31, 2022 | -2.824M |
| September 30, 2022 | -9.262M |
| June 30, 2022 | -7.484M |
| March 31, 2022 | -6.058M |
| December 31, 2021 | -5.535M |
| September 30, 2021 | -2.224M |
| June 30, 2021 | 6.235M |
| March 31, 2021 | -10.22M |
| December 31, 2020 | -7.825M |
| September 30, 2020 | -3.706M |
| June 30, 2020 | -8.047M |
| March 31, 2020 | -7.183M |
| December 31, 2019 | -3.715M |
| September 30, 2019 | -3.617M |
| June 30, 2019 | -5.207M |
| March 31, 2019 | -7.446M |
| December 31, 2018 | -4.192M |
| September 30, 2018 | 13.54M |
| June 30, 2018 | -8.109M |
| Date | Value |
|---|---|
| March 31, 2018 | -9.662M |
| December 31, 2017 | 17.30M |
| September 30, 2017 | -10.68M |
| June 30, 2017 | -8.942M |
| March 31, 2017 | -8.646M |
| December 31, 2016 | -7.455M |
| September 30, 2016 | -3.60M |
| June 30, 2016 | -12.02M |
| March 31, 2016 | -9.876M |
| December 31, 2015 | -3.861M |
| September 30, 2015 | -8.788M |
| June 30, 2015 | -5.579M |
| March 31, 2015 | -6.52M |
| December 31, 2014 | -5.042M |
| September 30, 2014 | -9.794M |
| June 30, 2014 | -6.627M |
| March 31, 2014 | -8.603M |
| December 31, 2013 | -4.964M |
| September 30, 2013 | -8.543M |
| June 30, 2013 | -8.808M |
| March 31, 2013 | -10.23M |
| December 31, 2012 | 1.57M |
| September 30, 2012 | -8.799M |
| June 30, 2012 | 12.89M |
| March 31, 2012 | -7.091M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-10.22M
Minimum
Mar 2021
6.235M
Maximum
Jun 2021
-3.711M
Average
-3.782M
Median
Jun 2024
Free Cash Flow (Quarterly) Benchmarks
| Accuray Inc | -8.414M |
| Aethlon Medical Inc | -1.748M |
| Predictive Oncology Inc | -3.224M |
| bluebird bio Inc | -66.31M |
| AIM ImmunoTech Inc | -3.237M |